Top brokers name 3 ASX small cap shares to buy

Immutep Ltd (ASX:IMM) and these small cap ASX shares have been named as buys by brokers. Here's why they are bullish on them…

| More on:
Businessman with hands on hips looks at share price chart with the words 'buy' and 'sell '

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As well as covering large caps like Afterpay Ltd (ASX: APT) and Telstra Corporation Ltd (ASX: TLS), many brokers also cover smaller companies.

In light of this, I thought I would scour through a range of recent notes to see which small cap ASX shares are in favour with brokers at present.

Three that have been given buy ratings are listed below. Here's why brokers like them:

Immutep Ltd (ASX: IMM)

According to a note out of Bell Potter, its analysts have a speculative buy rating and 85 cents price target on this biotechnology company's shares. The broker notes that Immutep has recently been granted Fast Track status by the US FDA for its efti product candidate. This relates to a trial for first line recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The broker has increased the probability of success for the treatment in response to this and envisages licensing deals in 2023 if all goes to plan. The Immutep share price is fetching 44.5 cents this afternoon.

Silk Laser Australia Ltd (ASX: SLA)

Analysts at Ord Minnett currently have a buy rating and $5.06 price target on this laser, skin care, and cosmetic injections company's shares. According to the note, the broker was very happy with Silk Laser's performance during the first half. It notes that demand was so strong that the company upgraded its earnings guidance. Positively, Ord Minnett appears confident that Silk can easily achieve the top end of its new guidance range. The Silk Laser share price is trading at $4.50 on Friday.

Telix Pharmaceuticals Ltd (ASX: TLX)

A note out of Wilsons reveals that its analysts have an overweight rating and $5.40 price target on this clinical-stage biopharmaceutical company's shares. According to the note, the broker was pleased to see Novartis report positive results from a trial of Lu-PSMA-617 for prostate cancer. It believes this development is a big positive for Telix, which has a similar therapy – TLX591-CDx. Its ProstACT trial starts soon and will test TLX591 as a second line therapy. The Telix share price is fetching $3.94 on Friday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Two people tired and resting after sports race.
Broker Notes

Fundie rates 2 ASX 200 stocks in short-term pain but with long-term gain potential

Blackwattle Investment Partners sees these 2 ASX 200 stocks as worthy of a buy and hold strategy.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Guess which beaten down ASX share is rocketing 11% today

Why are investors buying this beaten down stock? Let's find out.

Read more »

Broker working with share prices on computers.
Broker Notes

These 3 ASX All Ords stocks just got sizeable broker upgrades

Top brokers expect strong performance from these ASX All Ords stocks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans says these ASX 200 stocks can rise 30%

Big returns could be on the cards for buyers of these shares.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Here are the latest broker rating changes on 3 prominent ASX shares

Brokers have delivered a mixed bag this week.

Read more »

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.
Financial Shares

'Strong momentum': 2 ASX financial shares backed by top fundie for 2025

ASX financial shares had a strong trading session on Tuesday with several new price records set.

Read more »